Dakota Wealth Management Sells 3,020 Shares of Lam Research Corporation $LRCX

Key Points

• Dakota Wealth Management has decreased its holdings in Lam Research Corporation by 20.2%, selling 3,020 shares and now owns 11,953 shares worth approximately $1.16 million.
• Lam Research's stock price has seen analysts boost their target prices, with Oppenheimer raising it to $120.00 and the stock currently holds an average rating of "Moderate Buy".
• The company has announced a quarterly dividend increase from $0.23 to $0.26 per share, effective October 15th, indicating a 0.8% dividend yield.

Dakota Wealth Management lowered its holdings in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 20.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 11,953 shares of the semiconductor company's stock after selling 3,020 shares during the period. Dakota Wealth Management's holdings in Lam Research were worth $1,164,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of LRCX. Vanguard Group Inc. raised its stake in Lam Research by 6.9% during the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock worth $9,389,358,000 after buying an additional 8,364,375 shares during the last quarter. Nuveen LLC bought a new position in Lam Research during the first quarter worth $604,344,000. Price T Rowe Associates Inc. MD raised its stake in Lam Research by 99.7% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company's stock worth $417,242,000 after buying an additional 2,864,863 shares during the last quarter. Boston Partners raised its stake in Lam Research by 9,978.3% during the first quarter. Boston Partners now owns 2,350,362 shares of the semiconductor company's stock worth $170,787,000 after buying an additional 2,327,041 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in Lam Research by 8,736.4% during the first quarter. GAMMA Investing LLC now owns 2,137,962 shares of the semiconductor company's stock worth $155,430,000 after buying an additional 2,113,767 shares during the last quarter. Institutional investors own 84.61% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on LRCX shares. Stifel Nicolaus lifted their target price on shares of Lam Research from $92.00 to $110.00 and gave the stock a "buy" rating in a research note on Tuesday, July 29th. Oppenheimer lifted their target price on shares of Lam Research from $110.00 to $120.00 and gave the stock an "outperform" rating in a research note on Thursday, July 31st. Summit Insights cut shares of Lam Research from a "buy" rating to a "hold" rating in a report on Thursday, July 31st. Citigroup raised their price target on shares of Lam Research from $113.00 to $120.00 and gave the stock a "buy" rating in a report on Monday, September 8th. Finally, KeyCorp raised their price target on shares of Lam Research from $105.00 to $115.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Twenty research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $111.35.

Lam Research Stock Up 0.2%

Shares of NASDAQ LRCX opened at $128.33 on Friday. The stock has a market capitalization of $161.83 billion, a P/E ratio of 30.85, a P/E/G ratio of 1.62 and a beta of 1.76. The company has a 50-day moving average price of $106.28 and a 200-day moving average price of $90.20. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $133.57. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. The firm had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The business's revenue was up 33.6% on a year-over-year basis. During the same period last year, the company earned $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, equities research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th will be issued a dividend of $0.26 per share. This is an increase from Lam Research's previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 24th. Lam Research's dividend payout ratio is 25.00%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.